Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis release_vz4maggsunddxlp5owme3kbjmy

by Malgorzata Konieczynska, Korneliusz Fil, Marta Bazanek, Anetta Undas

Published in Thrombosis and Haemostasis by Schattauer GmbH.

2014   Volume 111, Issue 04, p685-693

Abstract

<jats:title>Summary</jats:title>It has been shown that type 2 diabetes (DM) is associated with enhanced thrombin generation and formation of denser fibrin clots of reduced lysability. We sought to investigate the impact of diabetes duration versus glycaemia control on fibrin clot phenotype and its determinants in type 2 diabetic patients. In 156 consecutive Caucasian patients with type 2 diabetes we investigated ex vivo thrombin generation, fibrinolytic proteins, along with plasma fibrin clot permeation (Ks ), compaction, turbidity, and efficiency of tissue plasminogen activator (t-PA)-mediated fibrinolysis. Patients with longer diabetes duration (&gt;5 years, median; n=68) had higher peak thrombin generation (+16.3%, p&lt;0.001), plasminogen activator inhibitor-1 (PAI-1) antigen (+14.8%, p=0.001), t-PA antigen (+13.9%, p=0.002) compared with those with duration ≤5 years (n=88). No such differences were observed between patients with inadequate glycaemic control, defined as glycated haemoglobin (HbA1C) &gt;6.5% (48 mmol/mol) (n=77), versus those with HbA1C ≤6.5% (n=79). Fibrinogen, thrombin-activatable fibrinolysis inhibitor antigen, plasminogen and soluble thrombomodulin were unaffected by disease duration or glycaemia control. Lower clot permeability, longer clot lysis, and higher maximum D-dimer levels released from clots (all p&lt;0.05 after adjustment for fibrinogen, age, body mass index, insulin, acetylsalicylic acid treatment, and HbA1c or diabetes duration) were also observed in patients with diabetes duration &gt;5 years and those with HbA1C &gt;6.5%. We conclude that prolonged duration of type 2 diabetes is associated with increased thrombin formation, hypofibrinolysis, and prothrombotic fibrin clot phenotype. The impact of disease duration on coagulation is different and stronger than that observed during inadequate glycaemia control.
In application/xml+jats format

Archived Files and Locations

application/pdf   1.7 MB
file_7adwpj7sf5ggfiwvt36kosrxly
application/pdf   1.8 MB
file_hgcdhawqyzewzlmkdsvy3d7cpe
web.archive.org (webarchive)
pdfs.semanticscholar.org (aggregator)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Year   2014
Language   en ?
DOI  10.1160/th13-07-0566
PubMed  24306139
Wikidata  Q54489366
Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  0340-6245
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 6e44c32d-af87-4870-9991-c11e0659d733
API URL: JSON